CompanyDrug

Sirnaomics’ STP705 Demonstrates Positive Results in Phase I Focal Fat Reduction Study

CompanyDeals

3SBio Inc. and CStone Pharmaceuticals Enter Strategic Partnership for Nofazinlimab

CompanyDeals

Resolian Expands Global Reach with Acquisition of China-Based Denali Medpharma

CompanyDrug

Hainan Poly Pharm Receives FDA Approval for PL002 in Primary Liver Cancer Surgery

CompanyDrug

Changchun BCHT Biotechnology Receives NMPA Approval for Anti-Tetanus Monoclonal Antibody Injection

CompanyDrug

Shenzhen Chipscreen Biosciences Gets NMPA Approval for Phase I Study of CS32582 in Psoriasis

CompanyDeals

Shanghai’s Argo Biopharma Raises USD 41 Million in Series A+ Financing Round

CompanyDeals

ImmuXell Biotech Secures Over RMB 100 Million in Series A Funding for Cell Therapy Development

CompanyDrug

Shanghai Henlius Biotech’s HanSiZhuang Shows Positive Results in Phase III ASTRUM-002 Study

CompanyDrug

Luye Pharma Group’s Rivastigmine Patch LY03013 Approved by China’s NMPA for Alzheimer’s Treatment

Company

Bio-Techne Corporation Reports 2% YOY Revenue Growth in Q1 2024 Fiscal Report

CompanyDrug

Novartis’ Cosentyx Gains FDA Approval for Hidradenitis Suppurativa Treatment